CCMG
ZBH icon

Clark Capital Management Group’s Zimmer Biomet ZBH Stock Holding History

Clark Capital Management Group’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-52,219
Closed -$5.23M – 327
2016
Q4 		$5.23M Sell
52,219
-17,811
-25% -$1.91M 0.27% 108
2016
Q3 		$8.84M Buy
70,030
+15,180
+28% +$1.88M 0.51% 60
2016
Q2 		$6.41M Buy
54,850
+23,476
+75% +$2.66M 0.41% 73
2016
Q1 		$3.25M Buy
+31,374
New +$3.04M 0.25% 101
2014
Q1 		– Sell
-2,750
Closed -$249K – 385
2013
Q4 		$249K Buy
+2,750
New +$238K 0.02% 298

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Clark Capital Management Group's ZBH Position: Q1 2017 in Review

Clark Capital Management Group sold out of Zimmer Biomet (ZBH) in Q1 2017, closing a stake of 52,219 shares — an estimated $5.23M sold.

Clark Capital Management Group first reported a position in ZBH in Q4 2013 and held it in 5 quarters. The position peaked at $8.84M in Q3 2016. 817 funds tracked by Wall St. Rank hold ZBH as of Q1 2017.

  • Clark Capital Management Group reported no remaining Zimmer Biomet position as of Q1 2017 after selling out during the quarter.
  • Clark Capital Management Group sold 52,219 Zimmer Biomet shares in Q1 2017, an estimated $5.23M.
  • Clark Capital Management Group first reported a position in Zimmer Biomet in Q4 2013 and held it in 5 quarters.
  • Clark Capital Management Group's Zimmer Biomet position peaked at $8.84M in Q3 2016.
  • 817 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2017.

Based on Clark Capital Management Group's 13F filing for Q1 2017, filed 11 May 2017.